TCBPY
TC BioPharm (Holdings) plcCompany Information
- Company Name
- TC BioPharm (Holdings) plc
- CIK
- CIK0001872812
- Category
- Non-accelerated filer<br>Emerging growth company
- Ticker: Exchange
- TCBPY: OTC, TCBWF: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- TCBPY
SEC filing data through
Insider Sentiment
- Last purchase
- 2022-11-30
- Last sale
- —
- Shares purchased (TTM)
- 300,803
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2023-09-30
- Institutional shares owned
- 421,835
- Shares outstanding
- 1,545
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2024-05-15
- Price on filing date
- —
- 1-month reaction
- -3.57%
- 3-month reaction
- -61.43%
Balance Sheet
Values in millions ($)| Line item | 2024-03-31 | 2023-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||
| Cash And Cash Equivalents At Carrying Value | 1 | 2 | ||||||
| Prepaid Expense And Other Assets Current | 2 | 2 | ||||||
| Assets Current | 4 | 6 | ||||||
Assets Noncurrent | ||||||||
| Property Plant And Equipment Net | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | ||||||
| Intangible Assets Net Excluding Goodwill | 1 | 1 | ||||||
| Assets | 7 | 9 | ||||||
Liabilities Current | ||||||||
| Accounts Payable And Accrued Liabilities Current | 4 | 4 | ||||||
| Derivative Liabilities Current | 0 | 0 | ||||||
| Operating Lease Liability Current | 0 | 0 | ||||||
| Liabilities Current | 5 | 5 | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | ||||||
| Liabilities | 6 | 6 | ||||||
Stockholders Equity | ||||||||
| Common Stock Value | 0 | 0 | ||||||
| Additional Paid In Capital | 43 | 41 | ||||||
| Retained Earnings Accumulated Deficit | -42 | -39 | ||||||
| Stockholders Equity | 1 | 3 | ||||||
| Liabilities And Stockholders Equity | 7 | 9 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 0 | 0 | ||||||
| Common Stock Shares Issued | 0 | 0 | ||||||
| Shares Outstanding | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialTC BioPharm (Holdings) plc (TCBPY) — SEC Financial Statements & Analysis
TC BioPharm (Holdings) plc (TCBPY) is a biological products, (no diagnostic substances) company, incorporated in X0. TC BioPharm (Holdings) plc trades on OTC as: TCBPY, TCBWF. TC BioPharm (Holdings) plc (TCBPY)'s most recent SEC filing is a Form 10-Q for the period ended 2024-03-31, filed with the SEC on 2024-05-15. Based on that filing, On the balance sheet, TC BioPharm (Holdings) plc maintains a current ratio of 0.88x, a quick ratio of 0.45x, working capital of $-560.82K, a debt-to-equity ratio of 5.72x, a debt ratio of 0.85, and net debt of $-980.96K. Figures sourced from SEC EDGAR.
- Debt To Equity
- 5.72x
Data as of 2024-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is TC BioPharm (Holdings) plc in?
TC BioPharm (Holdings) plc (TCBPY) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does TCBPY trade on?
TC BioPharm (Holdings) plc (TCBPY) trades on the OTC.
Where is TC BioPharm (Holdings) plc incorporated?
TC BioPharm (Holdings) plc is incorporated in United Kingdom.
When was TC BioPharm (Holdings) plc (TCBPY)'s most recent SEC filing?
TC BioPharm (Holdings) plc (TCBPY)'s most recent SEC filing is a Form 10-Q for the period ended 2024-03-31, filed with the SEC on 2024-05-15.